These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Structure-activity relationship studies and biological properties evaluation of peptidic NRP-1 ligands: Investigation of N-terminal cysteine importance. Puszko AK; Sosnowski P; Hermine O; Hopfgartner G; Lepelletier Y; Misicka A Bioorg Med Chem; 2023 Oct; 94():117482. PubMed ID: 37774449 [TBL] [Abstract][Full Text] [Related]
5. Branched pentapeptides as potent inhibitors of the vascular endothelial growth factor 165 binding to Neuropilin-1: Design, synthesis and biological activity. Tymecka D; Puszko AK; Lipiński PFJ; Fedorczyk B; Wilenska B; Sura K; Perret GY; Misicka A Eur J Med Chem; 2018 Oct; 158():453-462. PubMed ID: 30241012 [TBL] [Abstract][Full Text] [Related]
6. The functions and applications of A7R in anti-angiogenic therapy, imaging and drug delivery systems. Lu L; Chen H; Hao D; Zhang X; Wang F Asian J Pharm Sci; 2019 Nov; 14(6):595-608. PubMed ID: 32104486 [TBL] [Abstract][Full Text] [Related]
7. Urea moiety as amide bond mimetic in peptide-like inhibitors of VEGF-A Puszko AK; Sosnowski P; Pułka-Ziach K; Hermine O; Hopfgartner G; Lepelletier Y; Misicka A Bioorg Med Chem Lett; 2019 Sep; 29(17):2493-2497. PubMed ID: 31326342 [TBL] [Abstract][Full Text] [Related]
8. Antiangiogenic and antitumor activities of peptide inhibiting the vascular endothelial growth factor binding to neuropilin-1. Starzec A; Vassy R; Martin A; Lecouvey M; Di Benedetto M; Crépin M; Perret GY Life Sci; 2006 Nov; 79(25):2370-81. PubMed ID: 16959272 [TBL] [Abstract][Full Text] [Related]
9. Neuropilin-1 peptide-like ligands with proline mimetics, tested using the improved chemiluminescence affinity detection method. Puszko AK; Sosnowski P; Tymecka D; Raynaud F; Hermine O; Lepelletier Y; Misicka A Medchemcomm; 2019 Feb; 10(2):332-340. PubMed ID: 30881620 [TBL] [Abstract][Full Text] [Related]
10. Structure-activity relationship study of a small cyclic peptide H-c[Lys-Pro-Glu]-Arg-OH: a potent inhibitor of Vascular Endothelial Growth Factor interaction with Neuropilin-1. Grabowska K; Puszko AK; Lipiński PF; Laskowska AK; Wileńska B; Witkowska E; Perret GY; Misicka A Bioorg Med Chem; 2017 Jan; 25(2):597-602. PubMed ID: 27889287 [TBL] [Abstract][Full Text] [Related]
11. Does Cysteine Rule (CysR) Complete the CendR Principle? Increase in Affinity of Peptide Ligands for NRP-1 Through the Presence of N-Terminal Cysteine. Puszko AK; Sosnowski P; Raynaud F; Hermine O; Hopfgartner G; Lepelletier Y; Misicka A Biomolecules; 2020 Mar; 10(3):. PubMed ID: 32183142 [TBL] [Abstract][Full Text] [Related]
12. Chirality and Rigidity in Triazole-Modified Peptidomimetics Interacting with Neuropilin-1. Fedorczyk B; Redkiewicz P; Matalińska J; Piast R; Kosson P; Wieczorek R Pharmaceuticals (Basel); 2024 Jan; 17(2):. PubMed ID: 38399405 [TBL] [Abstract][Full Text] [Related]
13. Structure-function analysis of the antiangiogenic ATWLPPR peptide inhibiting VEGF(165) binding to neuropilin-1 and molecular dynamics simulations of the ATWLPPR/neuropilin-1 complex. Starzec A; Ladam P; Vassy R; Badache S; Bouchemal N; Navaza A; du Penhoat CH; Perret GY Peptides; 2007 Dec; 28(12):2397-402. PubMed ID: 17983687 [TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and in vitro biological evaluation of a small cyclic peptide as inhibitor of vascular endothelial growth factor binding to neuropilin-1. Grabowska K; Puszko AK; Lipiński PFJ; Laskowska AK; Wileńska B; Witkowska E; Misicka A Bioorg Med Chem Lett; 2016 Jun; 26(12):2843-2846. PubMed ID: 27142754 [TBL] [Abstract][Full Text] [Related]
15. Molecular modelling, synthesis and biological evaluation of peptide inhibitors as anti-angiogenic agent targeting neuropilin-1 for anticancer application. Kamarulzaman EE; Vanderesse R; Gazzali AM; Barberi-Heyob M; Boura C; Frochot C; Shawkataly O; Aubry A; Wahab HA J Biomol Struct Dyn; 2017 Jan; 35(1):26-45. PubMed ID: 26766582 [TBL] [Abstract][Full Text] [Related]
16. SPECT imaging of neuropilin receptor type-1 expression with 131I-labeled monoclonal antibody. Dou X; Yan J; Zhang Y; Liu P; Jiang Y; Lv S; Zeng F; Chen X; Wang S; Zhang H; Wu H; Zhang H; Ouyang L; Su X Int J Oncol; 2016 Sep; 49(3):961-70. PubMed ID: 27315007 [TBL] [Abstract][Full Text] [Related]